| 000 | 01904 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516220446.0 | ||
| 264 | 0 | _c20141223 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1536-3678 | ||
| 024 | 7 |
_a10.1097/MPH.0000000000000183 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDang, Daniel N | |
| 245 | 0 | 0 |
_aTherapy-induced secondary acute myeloid leukemia with t(11;19)(q23;p13.1) in a pediatric patient with relapsed acute promyelocytic leukemia. _h[electronic resource] |
| 260 |
_bJournal of pediatric hematology/oncology _cNov 2014 |
||
| 300 |
_ae546-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAnthracyclines _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 15 |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 19 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xchemically induced |
| 650 | 0 | 4 |
_aLeukemia, Promyelocytic, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoplasms, Second Primary _xgenetics |
| 650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
| 650 | 0 | 4 | _aPromyelocytic Leukemia Protein |
| 650 | 0 | 4 |
_aReceptors, Retinoic Acid _xgenetics |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetinoic Acid Receptor alpha |
| 650 | 0 | 4 |
_aTranscription Factors _xgenetics |
| 650 | 0 | 4 |
_aTretinoin _xadministration & dosage |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
| 700 | 1 | _aMorris, Heather D | |
| 700 | 1 | _aFeusner, James H | |
| 700 | 1 | _aKoduru, Prasad | |
| 700 | 1 | _aWilson, Kathleen | |
| 700 | 1 | _aTimmons, Charles F | |
| 700 | 1 | _aCavalier, MaryEllen | |
| 700 | 1 | _aLuu, Hung S | |
| 773 | 0 |
_tJournal of pediatric hematology/oncology _gvol. 36 _gno. 8 _gp. e546-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MPH.0000000000000183 _zAvailable from publisher's website |
| 999 |
_c23930922 _d23930922 |
||